Regen Biopharma dismisses auditor BF Borgers due to SEC cease-and-desist order

Regen BioPharma Inc

BF Borgers CPA PC dismissed as independent auditor effective May 10, 2024, following SEC order of May 3, 2024.
SEC order instituted administrative and cease-and-desist proceedings against BF Borgers and its sole partner.
No disagreements or reportable events occurred with BF Borgers during fiscal years 2022 and 2023.
Company will need to engage a new independent registered public accounting firm.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Regen BioPharma Inc dismissed BF Borgers CPA PC as its auditor.

Action: dismissal
Auditor: BF Borgers CPA PC

Exact text from the filing

On May 10, 2024 the Board of Directors of Regen Biopharma, Inc. (the “Company”) approved the dismissal; of BF Borgers CPA PC as the Company’s independent registered public accounting firm, effective immediately

View on SEC.gov

47 auditor changes filed in the last 30 days. Browse all auditor changes →

Regen BioPharma Inc filing history →

Source: SEC EDGAR

accession 0001607062-24-000175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.